Brendan Smith Stock Analyst Profile - TD Cowen Research Coverage - Stocknear

Brendan Smith

Stock Analyst at TD Cowen

(3.33)
# 2796
Out of 5,506 analysts
9
Total ratings
Success rate
Average return

7 Stocks

Name Action PT Current % Upside Ratings Updated
SLP Simulations Plus
Initiates Coverage On: Hold
16
16.02 -0.12% 1 Sep 30, 2025
DNA Ginkgo Bioworks Hold...
Maintains: Strong Buy
3 10
16.14 -38.04% 1 Sep 20, 2024
EXAI Exscientia
Downgrades: Hold
n/a
n/a n/a 2 Aug 9, 2024
HALO Halozyme Therapeutic...
Maintains: Strong Buy
59 65
68.98 -5.77% 2 Aug 7, 2024
NVAX Novavax
Maintains: Hold
5 10
9.46 5.71% 1 May 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jul 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Dec 5, 2022